Trademark: 90739913
Word
YARTEMLEASSURE PATIENT SUPPORT PROGRAM
Status Date
Monday, February 5, 2024
Filing Date
Thursday, May 27, 2021
Published for Opposition
Tuesday, May 10, 2022
Abandoned Date
Monday, February 5, 2024
41 Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions
16 Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support
36 Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; insurance services, namely, benefits verification in the nature of insurance claims administration; and providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders
35 Promoting awareness of patient support offerings for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; business administration of reimbursement and medical benefit information for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals
The mark consists of the trademark "YARTEMLEASSURE" in capital letters, with "YARTEMLEA" in purple, and "SSURE" in gold, in which the second letters "E" and "A" are connected with a thick gold curving line that goes from the middle horizontal line in the "E" and crosses the middle of the letter "A" and serves as its crossbar. The second letter "A" also features a gold sloping line to the right of and paralleling the right leg of that letter. The phrase "PATIENT SUPPORT PROGRAM" is below in a purple parallelogram with rounded upper right and lower left corners. The color white in the wording "PATIENT SUPPORT PROGRAM" indicates background and is not part of the mark.
YARTEM LEASSURE PATIENT SUPPORT PROGRAM; YARTEM LEISURE PATIENT SUPPORT PROGRAM
The color(s) purple and gold is/are claimed as a feature of the mark.
"PATIENT SUPPORT PROGRAM"
Feb 5, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 5, 2024
Abandonment - No Use Statement Filed
Jun 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 12, 2023
Sou Extension 2 Granted
Jun 12, 2023
Sou Extension 2 Filed
Jun 12, 2023
Sou Teas Extension Received
Oct 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 19, 2022
Sou Extension 1 Granted
Oct 19, 2022
Sou Extension 1 Filed
Oct 19, 2022
Sou Teas Extension Received
Jul 5, 2022
Noa E-Mailed - Sou Required From Applicant
May 10, 2022
Official Gazette Publication Confirmation E-Mailed
May 10, 2022
Published For Opposition
Apr 20, 2022
Notification Of Notice Of Publication E-Mailed
Apr 6, 2022
Law Office Publication Review Completed
Apr 2, 2022
Approved For Pub - Principal Register
Apr 1, 2022
Teas/Email Correspondence Entered
Mar 31, 2022
Correspondence Received In Law Office
Mar 31, 2022
Teas Response To Office Action Received
Mar 23, 2022
Notification Of Non-Final Action E-Mailed
Mar 23, 2022
Non-Final Action E-Mailed
Mar 23, 2022
Non-Final Action Written
Mar 2, 2022
Previous Allowance Count Withdrawn
Feb 22, 2022
Withdrawn From Pub - Og Review Query
Feb 10, 2022
Approved For Pub - Principal Register
Feb 10, 2022
Examiner's Amendment Entered
Feb 9, 2022
Assigned To Lie
Feb 9, 2022
Notification Of Examiners Amendment E-Mailed
Feb 9, 2022
Examiners Amendment E-Mailed
Feb 9, 2022
Examiners Amendment -Written
Feb 9, 2022
Assigned To Examiner
Nov 24, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Teas Change Of Owner Address Received
Aug 24, 2021
Notice Of Design Search Code E-Mailed
Aug 23, 2021
New Application Office Supplied Data Entered
May 31, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
